DJIA 17,042.90 -28.32 -0.17%
NASDAQ 4,493.39 0.00 0.00%
S&P 500 1,972.29 -5.51 -0.28%
market minute promo

ImmunoGen (NASDAQ: IMGN)

10.59 -0.58 (-5.19%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IMGN $10.59 -5.19%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.11
Previous Close $11.17
Daily Range $10.59 - $11.17
52-Week Range $10.28 - $18.19
Market Cap $909.8M
P/E Ratio -13.46
Dividend (Yield) $0.00 (0.0%)
Volume 907,668
Average Daily Volume 742,416
Current FY EPS -$0.70

Sector

Healthcare

Industry

Drugs

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website: http://www.immunogen.com/

News & Commentary Rss Feed

Breast Cancer Occurs Most Often in These 5 States

Breast cancer was diagnosed in more than 220,000 women in 2011. Find out in which five states a breast cancer diagnosis is the most common, as well as what current and developing therapies are being used to treat this terrible disease.

First Week of IMGN November 22nd Options Trading

Why ImmunoGen, Inc. Stock Crashed 22% in 2014

While the S&P Biotech index soars, ImmunoGen shareholders are getting left in the dust. Find out what's been holding shares back in 2014, and whether or not ImmunoGen will rebound from its current price.

SEC Slaps Biotech Hedge Fund for Short-Selling Violations

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

Trade-Ideas: Immunogen (IMGN) Is Today's Strong On High Relative Volume Stock

Why ImmunoGen (IMGN) Could Be Positioned for a Surge? - Tale of the Tape

Risk And Reward Seem Pretty Balanced At Seattle Genetics

ImmunoGen Q4 Loss Narrower than Expected, Provides Guidance - Analyst Blog

ImmunoGen's (IMGN) CEO Daniel Junius on Q4 2014 Results - Earnings Call Transcript

See More IMGN News...

IMGN's Top Competitors

IMGN $10.59 (-5.19%)
Current stock: IMGN
AMGN $140.46 (0.28%)
Current stock: AMGN
GILD $106.45 (-0.99%)
Current stock: GILD
BIIB $330.81 (0.20%)
Current stock: BIIB